PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Roma Pharmaceuticals Limited
RP

Roma Pharmaceuticals Limited

Burton-On-Trent
SME

Roma Pharmaceuticals is an independent pharmaceutical company focused on developing prescription pharmaceuticals for the UK market, particularly in areas of limited competition and clinical need. They also offer sales and marketing services for both their own products and those of other companies.

romapharma.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£412.7m
Live
9
Buyers
3
12m
£403.7m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities2
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts9 / 13
  • Top buyers3
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Roma Pharmaceuticals LimitedUpdated 20 Jul 2026

At a glance · for buyers and watchdogs

Roma Pharmaceuticals Limited has won £412.7m across 3 public-sector buyers, with 9 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
9 of 13Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 3
Sales & MarketingRoma has the capability to reach the whole UK market for both its own products and those of other companies. ↗Research & DevelopmentRoma manages the development of a range of pharmaceuticals in different therapeutic and clinical areas. ↗Business DevelopmentRoma works with partners to bring their products to the UK market or support them in marketing existing products. ↗
Frameworks & DPS · 2 from notices
  • NHS Framework Agreement for Branded medicines - NationalNHS England · £6.1m
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k

Extracted automatically from romapharma.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 9 live · 4 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS National Generics Pharmaceuticals Transition 2023_1
NHS England3360000001 Aug 2023£1.9m1.5 yrsClosed
NHS National Pharmaceuticals Transition 2022_1
NHS England and NHS Improvement3360000029 Jul 2022£944k1.8 yrsClosed
NHS Framework Agreement for Branded medicines - National
NHS England3360000001 May 2022£6.1m2 yrsClosed
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
NHS National Generic Pharmaceuticals Wave 15b
NHS England33600000———Live
NHS National Generic Pharmaceuticals Wave 14c
NHS England33600000———Live
NHS National Generics Pharmaceuticals Transition 2023_1
NHS England33600000———Live
NHS National Pharmaceuticals Transition 2022_1
NHS England33600000———Live
Total live value £0.02 · mean award £31.7m1–10 of 13

Top buyers · 3 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
11 contracts
100%
since 2022
2
NHS England and NHS Improvement
1 contract
0%
since 2022
3
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire12 contracts
100%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Roma Pharmaceuticals Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
RP
Roma Pharmaceuticals Limited
Yes£403.7m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 30 Jun 2025
Confirmation statement
Due in -32d
Next due 20 Jun 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
10217518
Status
Active
Type
Private limited
Incorporated
07 Jun 2016
Reg. office
Ground Floor, Gibraltar House Crown Square, First Avenue, Centrum One Hundred, Burton-On-Trent, DE14 2WE
SIC codes
21200
Last accounts
30 Jun 2025
Next accounts due
31 Mar 2027

Directors & PSC

  • WALLEY, Lucy — director
    Appointed 13 Jun 2024
  • WRIGHT, Philip John — director
    Appointed 11 Jun 2020
  • BROWN, Roland Alexander — director
    Appointed 07 Jun 2016
  • CRESSWELL, Mark — director
    Appointed 07 Jun 2016
  • Mr Roland Alexander Brown — person with significant control
    ownership of shares 25 to 50 percent
  • Mr Mark Cresswell — person with significant control
    ownership of shares 25 to 50 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
ROMA PHARMACEUTICALS LIMITED
10217518 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.